Research Institute: Institute for Molecular Bioscience, University of Queensland
Amount granted: $2.3 million
Year granted: 2016
The new cancer research facility will provide cutting-edge imaging capabilities for tracking and visualising cancer.
Researchers will be able to see cancer cells grow, spread and respond to drugs in real time. The three new microscopes at IMB will allow researchers to observe the structure and function of living cancer cells in real time with unprecedented resolution, giving them the opportunity to optimally target and fine-tune cancer treatments.
The new ACRF Cancer Ultrastructure and Function Facility represents an apex of multidisciplinary efforts. Biologists, physicians and chemists will work together to build a deeper understanding of cancer biology and pioneer new therapeutic approaches to beat cancer.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.